16 October 2023

Champalimaud Foundation scientists create health data cloud infrastructure for research for the first time in Portugal

A novel infrastructure for storing, consulting and analysing medical data will be presented at the Open Day of the Champalimaud Foundation (FC) Breast Unit, which is taking place today, October 16. It was created by the Unit's Digital Surgery Lab, a multidisciplinary team led by surgeon Pedro Gouveia, in partnership with the telecommunications company Altice and the Portuguese company BMD Software.

Miguel Patrício

Marta Barbosa

Nuno Loução

28 September 2023

Check Up #18 - Side effects of cancer treatments. Can we classify them?

A side-effect “is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant”. 

Challenging Malignant Melanoma

Malignant melanoma is a highly aggressive form of skin cancer that is on the rise. However, recent breakthrough research has introduced new targeted therapies and immunotherapies for melanoma treatment, transforming the approach to treating melanoma and offering hope to patients with limited alternatives.

Rita Cavaglià

Mariana Monteiro

21 September 2023

Mending eyes in a conflict-ridden region of the world

In the midst of a territory that has long been a hotspot for armed confrontation and humanitarian instability, the St John of Jerusalem Eye Hospital Group (SJEHG) has managed to provide top quality eye care, as well as ophthalmic training to local medical professionals. 

“For its commitment to providing essential eye care in a region marked by conflict”, the Group has now been recognized with the one-million-euro 2023 António Champalimaud Vision Award, the Champalimaud Foundation announced in a statement.

Pedro Cruz

Subscribe to Researchers
Loading
Please wait...